FDA approves once-daily Idvynso tablet for treating HIV Medical XpressProtective Blood Stem Cell Clones May Restore Bone Marrow Function in Aplastic Anemia Patients geneonline.comFDA Alert: Infectious Diseases Drug News Roundup 2026 Infectious Disease AdvisorMerck & Co. (MRK) – FDA Approval of First-In-Class HIV Therapy IDVYNSO Drives Bullish Long-Term Outlook – Strategic Review NewserDoes Merck’s Upgraded 2026 Outlook And New HIV Approval Reshape The Bull Case For MRK? Yahoo Finance
